Cardiff Oncology Files SEC Form 8-K Highlighting Item 5.02 and 5.03 Disclosures
Cardiff Oncology, Inc. submitted an SEC Form 8-K filing on Monday, October 26, 2026, detailing material corporate governance updates under Items 5.02 and 5.03. Market participants tracking life sciences regulatory disclosures should review the official documentation for governance shifts.
Market participants analyzing corporate governance disclosures should review the primary regulatory text on for specific management transition timelines.